M
Mario Di Napoli
Researcher at University of L'Aquila
Publications - 189
Citations - 6161
Mario Di Napoli is an academic researcher from University of L'Aquila. The author has contributed to research in topics: Stroke & Intracerebral hemorrhage. The author has an hindex of 35, co-authored 182 publications receiving 4871 citations.
Papers
More filters
Journal ArticleDOI
C-reactive protein in ischemic stroke: an independent prognostic factor.
TL;DR: CRP at discharge is better related to later outcome and could be of greater utility for risk stratification and consistent with the hypothesis that elevated CRP may predict future cardiovascular events or death in ischemic stroke.
Journal ArticleDOI
Prognostic Influence of Increased C-Reactive Protein and Fibrinogen Levels in Ischemic Stroke
TL;DR: Increased levels of CRP are associated with a worse outcome in patients with ischemic stroke, and the increased risk associated with elevated CRP levels is independent of the prognostic influence of fibrinogen.
Journal ArticleDOI
Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: a statement for health care professionals from the CRP Pooling Project members.
Mario Di Napoli,Markus Schwaninger,Roberto Cappelli,Elena Ceccarelli,Giacinto Di Gianfilippo,Cristina Donati,Hedley C. A. Emsley,Sandro Forconi,Stephen J. Hopkins,Luca Masotti,Keith W. Muir,Anna Paciucci,Francesca Papa,Sabina Roncacci,Dirk Sander,K. Sander,Craig J. Smith,Alessandro Stefanini,Daniela Weber +18 more
TL;DR: There is not sufficient evidence to recommend measurement of CRP in the routine evaluation of cerebrovascular disease risk in primary prevention, because there is insufficient evidence as to whether early detection, or intervention based on detection, improves health outcomes, although shared risk of cardiovascular disease indicates this may be of value.
Journal ArticleDOI
Neuroinflammation and Cerebrovascular Disease in Old Age: A Translational Medicine Perspective
Mario Di Napoli,Imtiaz M. Shah +1 more
TL;DR: Molecular aspects of acute stroke and senescence from a bench-to-bedside research perspective are discussed and inflammatory pathways and oxidative stress remain attractive therapeutic targets for the development of adjuvant neuroprotective agents.
Journal ArticleDOI
Diagnosis of Stroke-Associated Pneumonia: Recommendations From the Pneumonia in Stroke Consensus Group
Craig J. Smith,Amit Kishore,Andy Vail,Ángel Chamorro,Javier Garau,Stephen J. Hopkins,Mario Di Napoli,Lalit Kalra,Peter Langhorne,Joan Montaner,Christine Roffe,Anthony Rudd,Pippa J. Tyrrell,Diederik van de Beek,Mark Woodhead,Andreas Meisel +15 more
TL;DR: Stroke-associated pneumonia (SAP) is the recommended terminology for the spectrum of lower respiratory tract infections within the first 7 days after stroke onset and modified Centers for Disease Control and Prevention (CDC) criteria are proposed for SAP.